Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Lung Cancer

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 159 articles:
HTML format



Single Articles


    November 2020
  1. YUAN J, Xing H, Li Y, Song Y, et al
    EPB41 suppresses the Wnt/beta-catenin signaling in non-small cell lung cancer by sponging ALDOC.
    Cancer Lett. 2020 Nov 24. pii: S0304-3835(20)30622.
    PubMed     Abstract available


  2. SHIH CT, Shiau CW, Chen YL, Chen LJ, et al
    TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1.
    Cancer Lett. 2020 Nov 21. pii: S0304-3835(20)30577.
    PubMed     Abstract available


  3. LI J, Gao A, Zhang F, Wang S, et al
    ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer.
    Cancer Lett. 2020 Nov 2. pii: S0304-3835(20)30582.
    PubMed     Abstract available


    October 2020
  4. HAQUE A, Rahman MA, Fuchs JR, Chen Z, et al
    Corrigendum to "FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway" [Canc. Lett. 363 (2015) 166-175].
    Cancer Lett. 2020 Oct 20. pii: S0304-3835(20)30395.
    PubMed    


    September 2020
  5. PARK S, Kim TM, Cho SY, Kim S, et al
    Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells.
    Cancer Lett. 2020;495:135-144.
    PubMed     Abstract available


  6. QUAN C, Chen Y, Wang X, Yang D, et al
    Loss of histone lysine methyltransferase EZH2 confers resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
    Cancer Lett. 2020 Sep 10. pii: S0304-3835(20)30465.
    PubMed     Abstract available


  7. MAHMUD F, Deng S, Chen H, Miller DD, et al
    Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer.
    Cancer Lett. 2020 Sep 10. pii: S0304-3835(20)30466.
    PubMed     Abstract available


  8. ZENG Y, Jie X, Wu B, Wu G, et al
    IQGAP3 interacts with Rad17 to recruit the Mre11-Rad50-Nbs1 complex and contributes to radioresistance in lung cancer.
    Cancer Lett. 2020 Sep 4. pii: S0304-3835(20)30456.
    PubMed     Abstract available


    August 2020
  9. WANG C, Tan S, Li J, Liu WR, et al
    CircRNAs in lung cancer - Biogenesis, function and clinical implication.
    Cancer Lett. 2020 Aug 26. pii: S0304-3835(20)30427.
    PubMed     Abstract available


  10. SHOU J, You L, Yao J, Xie J, et al
    Corrigendum to "Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3" [Canc Lett 379 (2016) 124-133].
    Cancer Lett. 2020;493:13-15.
    PubMed    


  11. TIAN D, Tang J, Geng X, Li Q, et al
    Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy.
    Cancer Lett. 2020 Aug 16. pii: S0304-3835(20)30421.
    PubMed     Abstract available


  12. CASAL-MOURINO A, Ruano-Ravina A, Torres-Duran M, Parente-Lamelas I, et al
    Corrigendum to "Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study" [Canc. Lett. 487 (2020) 21-26].
    Cancer Lett. 2020;493:10.
    PubMed    


  13. WANG D, Cong J, Fu B, Zheng X, et al
    Immunogenic chemotherapy effectively inhibits KRAS-Driven lung cancer.
    Cancer Lett. 2020 Aug 3. pii: S0304-3835(20)30399.
    PubMed     Abstract available


  14. GALLAND S, Martin P, Fregni G, Letovanec I, et al
    Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins.
    Cancer Lett. 2020;484:50-64.
    PubMed     Abstract available


    June 2020
  15. YIN H, Wang X, Zhang X, Zeng Y, et al
    UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
    Cancer Lett. 2020 Jun 23. pii: S0304-3835(20)30331.
    PubMed     Abstract available


  16. HUANG XH, Yan X, Zhang QH, Hong P, et al
    Direct targeting of HSP90 with daurisoline destabilizes beta-catenin to suppress lung cancer tumorigenesis.
    Cancer Lett. 2020 Jun 13. pii: S0304-3835(20)30286.
    PubMed     Abstract available


    May 2020
  17. MOURINO AC, Ruano-Ravina A, Torres-Duran M, Parente-Lamelas I, et al
    Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study.
    Cancer Lett. 2020 May 23. pii: S0304-3835(20)30284.
    PubMed     Abstract available


  18. ZHAO Z, Zhang N, Li A, Zhou B, et al
    Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway.
    Cancer Lett. 2020 May 14. pii: S0304-3835(20)30199.
    PubMed     Abstract available


  19. YANG YF, Wang YY, Hsiao M, Lo S, et al
    IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway.
    Cancer Lett. 2020 May 14. pii: S0304-3835(20)30227.
    PubMed     Abstract available


    April 2020
  20. CHEN J, Liu A, Lin Z, Wang B, et al
    Downregulation of the Circadian Rhythm Regulator HLF Promotes Multiple-Organ Distant Metastases in Non-Small Cell Lung Cancer through PPAR/NF-kappaB Signaling.
    Cancer Lett. 2020 Apr 11. pii: S0304-3835(20)30184.
    PubMed     Abstract available


    March 2020
  21. LI Y, Liang R, Sun M, Li Z, et al
    AMPK-Dependent Phosphorylation of HDAC8 Triggers PGM1 Expression to Promote Lung Cancer Cell Survival under Glucose Starvation.
    Cancer Lett. 2020 Mar 11. pii: S0304-3835(20)30126.
    PubMed     Abstract available


  22. VANBERVLIET-DEFRANCE B, Delaunay T, Daunizeau T, Kepenekian V, et al
    Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma.
    Cancer Lett. 2020;472:29-39.
    PubMed     Abstract available


    February 2020
  23. ZHENG J, Zhang Y, Cai S, Dong L, et al
    MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression.
    Cancer Lett. 2020;476:129-139.
    PubMed     Abstract available


    January 2020
  24. XIAO R, Ding C, Zhu H, Liu X, et al
    Suppression of asparagine synthetase enhances the antitumor potency of ART and artemalogue SOMCL-14-221 in non-small cell lung cancer.
    Cancer Lett. 2020 Jan 31. pii: S0304-3835(20)30049.
    PubMed     Abstract available


  25. TAN HY, Wang N, Chan YT, Zhang C, et al
    ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis.
    Cancer Lett. 2020 Jan 28. pii: S0304-3835(20)30039.
    PubMed     Abstract available


  26. SEIDL C, Panzitt K, Bertsch A, Brcic L, et al
    MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
    Cancer Lett. 2020;469:266-276.
    PubMed     Abstract available


  27. ZHANG L, Zhang X, Liu Y, Zhang T, et al
    PD-L1(+) aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients.
    Cancer Lett. 2020;469:355-366.
    PubMed     Abstract available


  28. ZHOU Y, Zhou Y, Wang K, Li T, et al
    Flumethasone enhances the efficacy of chemotherapeutic drugs in lung cancer by inhibiting Nrf2 signaling pathway.
    Cancer Lett. 2020 Jan 16. pii: S0304-3835(20)30018.
    PubMed     Abstract available


  29. YU JJ, Zhou DD, Cui B, Zhang C, et al
    Disruption of the EGFR-SQSTM1 Interaction by a Stapled Peptide Suppresses Lung Cancer via Activating Autophagy and Inhibiting EGFR Signaling.
    Cancer Lett. 2020 Jan 10. pii: S0304-3835(20)30012.
    PubMed     Abstract available


  30. ZHOU Z, Zhou Q, Wu X, Xu S, et al
    VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling.
    Cancer Lett. 2020;473:62-73.
    PubMed     Abstract available


    December 2019
  31. LI Y, Chen F, Shen W, Li B, et al
    WDR74 induces nuclear beta-catenin accumulation and activates Wnt-responsive genes to promote lung cancer growth and metastasis.
    Cancer Lett. 2019 Dec 12. pii: S0304-3835(19)30617.
    PubMed     Abstract available


  32. LI X, Tong LJ, Ding J, Meng LH, et al
    Corrigendum to "Systematic combination screening reveals synergism between rapamycin and sutent against human lung cancer" [Cancer Letter 342(2014) 159-166].
    Cancer Lett. 2019 Dec 6. pii: S0304-3835(19)30592.
    PubMed    


    October 2019
  33. ZHANG L, Zhu B, Zeng Y, Shen H, et al
    Clinical Lipidomics In Understanding Of Lung Cancer: Opportunity And Challenge.
    Cancer Lett. 2019 Oct 23. pii: S0304-3835(19)30451.
    PubMed     Abstract available


  34. LIU C, Zheng S, Jin R, Wang X, et al
    The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.
    Cancer Lett. 2019 Oct 20. pii: S0304-3835(19)30524.
    PubMed     Abstract available


  35. YANG D, Liu Y, Bai C, Wang X, et al
    Epidemiology of lung cancer and lung cancer screening program in China and the United States.
    Cancer Lett. 2019 Oct 7. pii: S0304-3835(19)30500.
    PubMed     Abstract available


    September 2019
  36. HAMMAD A, Namani A, Elshaer M, Wang XJ, et al
    "NRF2 Addiction" in Lung Cancer Cells and Its Impact on Cancer Therapy.
    Cancer Lett. 2019 Sep 28. pii: S0304-3835(19)30488.
    PubMed     Abstract available


  37. REDA M, Ngamcherdtrakul W, Gu S, Bejan DS, et al
    PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer.
    Cancer Lett. 2019 Sep 26. pii: S0304-3835(19)30486.
    PubMed     Abstract available


  38. ZOU H, Chen H, Zhou Z, Wan Y, et al
    ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4.
    Cancer Lett. 2019 Sep 26. pii: S0304-3835(19)30484.
    PubMed     Abstract available


  39. KIM YJ, Baek DS, Lee S, Park D, et al
    Dual-targeting of EGFR and Neuropilin-1 Attenuates Resistance to EGFR-targeted Antibody Therapy in KRAS-mutant Non-Small Cell Lung Cancer.
    Cancer Lett. 2019 Sep 12. pii: S0304-3835(19)30469.
    PubMed     Abstract available


    August 2019
  40. KUANG Y, Wang Q
    Iron and Lung Cancer.
    Cancer Lett. 2019 Aug 19. pii: S0304-3835(19)30438.
    PubMed     Abstract available


  41. FOURNEL L, Wu Z, Stadler N, Damotte D, et al
    Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.
    Cancer Lett. 2019 Aug 9. pii: S0304-3835(19)30428.
    PubMed     Abstract available


    June 2019
  42. ZHANG YC, Zhou Q, Wu YL
    Clinical management of third-generation EGFR inhibitor-resistant patients with advanced non-small cell lung cancer: current status and future perspectives.
    Cancer Lett. 2019 Jun 12. pii: S0304-3835(19)30346.
    PubMed     Abstract available


    May 2019
  43. FLAHERTY RL, Intabli H, Falcinelli M, Bucca G, et al
    Stress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase.
    Cancer Lett. 2019 May 24. pii: S0304-3835(19)30322.
    PubMed     Abstract available


  44. LI Y, Acharya G, Elahy M, Xin H, et al
    The Anthelmintic Flubendazole Blocks Human Melanoma Growth and Metastasis and Suppresses Programmed Cell Death Protein-1 and Myeloid-Derived Suppressor Cell Accumulation.
    Cancer Lett. 2019 May 22. pii: S0304-3835(19)30321.
    PubMed     Abstract available


  45. LIU X, Pu W, He H, Fan X, et al
    Novel ROR1 Inhibitor ARI-1 Suppresses the Development of Non-Small Cell Lung Cancer.
    Cancer Lett. 2019 May 21. pii: S0304-3835(19)30311.
    PubMed     Abstract available


    April 2019
  46. SINGHAL J, Chikara S, Horne D, Salgia R, et al
    RLIP inhibition suppresses breast-to-lung metastasis.
    Cancer Lett. 2019;447:24-32.
    PubMed     Abstract available


    March 2019
  47. LI L, Wang Y, Jiao L, Lin C, et al
    Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer.
    Cancer Lett. 2019 Mar 22. pii: S0304-3835(19)30183.
    PubMed     Abstract available


  48. EXPOSITO F, Villalba M, Redrado M, de Aberasturi AL, et al
    Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.
    Cancer Lett. 2019 Mar 21. pii: S0304-3835(19)30169.
    PubMed     Abstract available


  49. SHIMOMURA I, Yokoi A, Kohama I, Kumazaki M, et al
    Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancer.
    Cancer Lett. 2019;451:11-22.
    PubMed     Abstract available


  50. CASAL-MOURINO A, Valdes L, Barros-Dios JM, Ruano-Ravina A, et al
    Lung cancer survival among never smokers.
    Cancer Lett. 2019 Mar 6. pii: S0304-3835(19)30133.
    PubMed     Abstract available


  51. CAO L, Wang F, Li S, Wang X, et al
    PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
    Cancer Lett. 2019;444:116-126.
    PubMed     Abstract available


  52. LI JY, Xiao T, Yi HM, Yi H, et al
    S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties.
    Cancer Lett. 2019;444:162-174.
    PubMed     Abstract available


    February 2019
  53. LI L, Wang Y, Song G, Zhang X, et al
    HOX cluster-embedded antisense long non-coding RNAs in lung cancer.
    Cancer Lett. 2019 Feb 23. pii: S0304-3835(19)30114.
    PubMed     Abstract available


  54. RUANO-RAVINA A, Rodriguez-Martinez A, Torres-Duran M, Barros-Dios JM, et al
    Reply: Residential radon and small cell lung cancer. A systematic review.
    Cancer Lett. 2019 Feb 4. pii: S0304-3835(19)30056.
    PubMed    


  55. BEVELACQUA JJ, Dobrzynski L, Welsh J, Mortazavi SMJ, et al
    Commentary regarding "Residential radon and small cell lung cancer. A systematic review".
    Cancer Lett. 2019 Feb 4. pii: S0304-3835(19)30050.
    PubMed     Abstract available


  56. CAPPELLI HC, Kanugula AK, Adapala RK, Amin V, et al
    Mechanosensitive TRPV4 channels stabilize VE-cadherin junctions to regulate tumor vascular integrity and metastasis.
    Cancer Lett. 2019;442:15-20.
    PubMed     Abstract available


    January 2019
  57. LIU X, Min S, Wu N, Liu H, et al
    miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
    Cancer Lett. 2019;447:56-65.
    PubMed     Abstract available


  58. NEGI H, Merugu SB, Mangukiya HB, Li Z, et al
    Anterior Gradient-2 Monoclonal Antibody Inhibits Lung Cancer Growth and Metastasis by Upregulating p53 Pathway and Without Exerting Any Toxicological Effects: A Preclinical Study.
    Cancer Lett. 2019 Jan 24. pii: S0304-3835(19)30045.
    PubMed     Abstract available


  59. HUANG H, Wang Y, Li Q, Fei X, et al
    miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9.
    Cancer Lett. 2019 Jan 17. pii: S0304-3835(19)30019.
    PubMed     Abstract available


  60. JUNG PY, Ryu H, Rhee KJ, Hwang S, et al
    Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-beta and TRAIL and suppress the growth of H460 human lung cancer cells.
    Cancer Lett. 2019;440-441:202-210.
    PubMed     Abstract available


  61. HAN Y, Guo W, Ren T, Huang Y, et al
    Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis.
    Cancer Lett. 2019;440-441:116-125.
    PubMed     Abstract available


  62. JI N, Yang Y, Cai CY, Lei ZN, et al
    Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.
    Cancer Lett. 2019;440-441:82-93.
    PubMed     Abstract available


  63. VELLANKI SH, Cruz RGB, Jahns H, Hudson L, et al
    Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth.
    Cancer Lett. 2019;440-441:23-34.
    PubMed     Abstract available


    December 2018
  64. PARK JH, Jung KH, Kim SJ, Yoon YC, et al
    HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30721.
    PubMed     Abstract available


  65. WU Z, Fournel L, Stadler N, Liu J, et al
    Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by Neurotensin antibody.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30722.
    PubMed     Abstract available


    November 2018
  66. LUKIC A, Wahlund CJE, Gomez C, Brodin D, et al
    Exosomes and cells from lung cancer pleura exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1.
    Cancer Lett. 2018 Nov 30. pii: S0304-3835(18)30699.
    PubMed     Abstract available


  67. GU J, Mao W, Ren W, Xu F, et al
    Ubiquitin-protein Ligase E3C Maintains Non-small-cell Lung Cancer Stemness by Targeting AHNAK-p53 Complex.
    Cancer Lett. 2018 Nov 29. pii: S0304-3835(18)30695.
    PubMed     Abstract available


  68. TREMBLE LF, O'Brien MA, Forde PF
    Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer.
    Cancer Lett. 2018 Nov 22. pii: S0304-3835(18)30680.
    PubMed     Abstract available


  69. HUANG WT, Chong IW, Chen HL, Li CY, et al
    Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1.
    Cancer Lett. 2018 Nov 12. pii: S0304-3835(18)30646.
    PubMed     Abstract available


  70. YU L, Wang L, Mao C, Duraki D, et al
    Estrogen-Independent Myc Overexpression Confers Endocrine Therapy Resistance on Breast Cancer Cells Expressing ERalphaY537S and ERalphaD538G Mutations.
    Cancer Lett. 2018 Nov 9. pii: S0304-3835(18)30662.
    PubMed     Abstract available


    October 2018
  71. ZHANG P, Kang B, Xie G, Li S, et al
    Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.
    Cancer Lett. 2018;442:53-67.
    PubMed     Abstract available


  72. GUPTA P, Gupta N, Fofaria NM, Ranjan A, et al
    HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells.
    Cancer Lett. 2018;442:68-81.
    PubMed     Abstract available


  73. WANG Z, Fu S, Zhao J, Zhao W, et al
    Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer.
    Cancer Lett. 2018 Oct 19. pii: S0304-3835(18)30628.
    PubMed     Abstract available


    September 2018
  74. DI W, Yang B, Chen J, Xiong H, et al
    Upregulation of long non-coding RNA RAB1A-2 induces FGF1 expression worsening lung cancer prognosis.
    Cancer Lett. 2018 Sep 11. pii: S0304-3835(18)30571.
    PubMed     Abstract available


    August 2018
  75. WANG Y, Wu L, Yao Y, Lu G, et al
    Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
    Cancer Lett. 2018;436:1-9.
    PubMed     Abstract available


    July 2018
  76. CHIANG CT, Demetriou AN, Ung N, Choudhury N, et al
    mTORC2 contributes to the metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer.
    Cancer Lett. 2018 Jul 20. pii: S0304-3835(18)30483.
    PubMed     Abstract available


  77. ZHANG DL, Qu LW, Ma L, Zhou YC, et al
    Genome-wide identification of transcription factors that are critical to non-small cell lung cancer.
    Cancer Lett. 2018 Jul 18. pii: S0304-3835(18)30478.
    PubMed     Abstract available


  78. LEE YS, Jung YY, Park MH, Yeo IJ, et al
    Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitination.
    Cancer Lett. 2018;433:156-164.
    PubMed     Abstract available


    June 2018
  79. LU Z, Li Y, Che Y, Huang J, et al
    The TGFbeta-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
    Cancer Lett. 2018;432:156-168.
    PubMed     Abstract available


    May 2018
  80. LU T, Li Z, Yang Y, Ji W, et al
    Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46].
    Cancer Lett. 2018 May 10. pii: S0304-3835(18)30275.
    PubMed    


  81. HSU HY, Lin TY, Hu CH, Shu DTF, et al
    Fucoidan Upregulates TLR4/CHOP-Mediated Caspase-3 and PARP Activation to Enhance Cisplatin-Induced Cytotoxicity in Human Lung Cancer Cells.
    Cancer Lett. 2018 May 7. pii: S0304-3835(18)30325.
    PubMed     Abstract available


    April 2018
  82. GUERARD M, Robin T, Perron P, Hatat AS, et al
    Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI.
    Cancer Lett. 2018;420:146-155.
    PubMed     Abstract available


  83. DU Q, Yan C, Wu SG, Zhang W, et al
    Development and validation of a novel diagnostic nomogram model based on tumor markers for assessing cancer risk of pulmonary lesions: A multicenter study in Chinese population.
    Cancer Lett. 2018;420:236-241.
    PubMed     Abstract available


  84. YU F, Liu JB, Wu ZJ, Xie WT, et al
    Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30289.
    PubMed     Abstract available


  85. ZHAO X, Wu X, Qian M, Song Y, et al
    Knockdown of TGF-beta1 expression in human umbilical cord mesenchymal stem cells reverts their exosome-mediated EMT promoting effect on lung cancer cells.
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30293.
    PubMed     Abstract available


  86. TAN W, Liao Y, Qiu Y, Liu H, et al
    miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP).
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30295.
    PubMed     Abstract available


  87. JING P, Zhao N, Ye M, Zhang Y, et al
    Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Cancer Lett. 2018 Apr 18. pii: S0304-3835(18)30286.
    PubMed     Abstract available


  88. YU X, Zhang Y, Ma X, Pertsemlidis A, et al
    miR-195 Potentiates the Efficacy of Microtubule-Targeting Agents in Non-Small Cell Lung Cancer.
    Cancer Lett. 2018 Apr 13. pii: S0304-3835(18)30268.
    PubMed     Abstract available


  89. RODRIGUEZ-MARTINEZ A, Torres-Duran M, Barros-Dios JM, Ruano-Ravina A, et al
    Residential radon and small cell lung cancer. A systematic review.
    Cancer Lett. 2018 Apr 11. pii: S0304-3835(18)30264.
    PubMed     Abstract available


  90. HU W, Bi ZY, Chen ZL, Liu C, et al
    Emerging landscape of circular RNAs in lung cancer.
    Cancer Lett. 2018 Apr 10. pii: S0304-3835(18)30267.
    PubMed     Abstract available


  91. YAN C, Luo L, Urata Y, Goto S, et al
    Nicaraven reduces cancer metastasis to irradiated lungs by decreasing CCL8 and macrophage recruitment.
    Cancer Lett. 2018;418:204-210.
    PubMed     Abstract available


    March 2018
  92. LI D, Wang H, Ding Y, Zhang Z, et al
    Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.
    Cancer Lett. 2018;424:97-108.
    PubMed     Abstract available


  93. LE HT, Nguyen HT, Min HY, Hyun SY, et al
    Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Canc. Lett. 412 (2018) 297-307].
    Cancer Lett. 2018 Mar 21. pii: S0304-3835(18)30220.
    PubMed    


  94. CAO X, Zhou Y, Sun H, Xu M, et al
    EGFR-TKI-induced HSP70 degradation and BER suppression facilitate the occurrence of the EGFR T790M resistant mutation in lung cancer cells.
    Cancer Lett. 2018 Mar 7. pii: S0304-3835(18)30193.
    PubMed     Abstract available


  95. ZHANG GN, Zhang YK, Wang YJ, Gupta P, et al
    Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo.
    Cancer Lett. 2018 Mar 5. pii: S0304-3835(18)30181.
    PubMed     Abstract available


    February 2018
  96. YANG YF, Lee YC, Lo S, Chung YN, et al
    A positive feedback loop of IL-17B-IL-17RB activates ERK/beta-catenin to promote lung cancer metastasis.
    Cancer Lett. 2018;422:44-55.
    PubMed     Abstract available


  97. GOU W, Zhou X, Liu Z, Wang L, et al
    CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.
    Cancer Lett. 2018 Feb 22. pii: S0304-3835(18)30171.
    PubMed     Abstract available


  98. LU T, Li Z, Yang Y, Ji W, et al
    The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
    Cancer Lett. 2018 Feb 13. pii: S0304-3835(18)30142.
    PubMed     Abstract available


  99. SAIJO A, Goto H, Nakano M, Mitsuhashi A, et al
    Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells.
    Cancer Lett. 2018 Feb 12. pii: S0304-3835(18)30143.
    PubMed     Abstract available


  100. TANG ZH, Lu JJ
    Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies.
    Cancer Lett. 2018 Feb 6. pii: S0304-3835(18)30129.
    PubMed     Abstract available


  101. ZHANG Y, Lin Q, Xu T, Deng W, et al
    Out of the darkness and into the light: New strategies for improving treatments for locally advanced non-small cell lung cancer.
    Cancer Lett. 2018 Feb 6. pii: S0304-3835(18)30128.
    PubMed     Abstract available


  102. CHAI S, Qian Y, Tang J, Liang Z, et al
    Retraction notice to "Ca2+/Calmodulin-dependent protein kinase IIgamma, a critical mediator of the NF-kappaB network, is a novel therapeutic target in non-small cell lung cancer" [Cancer Lett. 344(1) (2014) 119-128].
    Cancer Lett. 2018;414:312.
    PubMed    


  103. GRUNDEMANN C, Huber R
    Chemoprevention with isothiocyanates - From bench to bedside.
    Cancer Lett. 2018;414:26-33.
    PubMed     Abstract available


    January 2018
  104. LI K, Sun D, Gou Q, Ke X, et al
    Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells.
    Cancer Lett. 2018 Jan 30. pii: S0304-3835(18)30093.
    PubMed     Abstract available


  105. ZHANG Y, Zhang X, Ye M, Jing P, et al
    FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
    Cancer Lett. 2018 Jan 17. pii: S0304-3835(18)30069.
    PubMed     Abstract available


  106. LI C, Wan L, Liu Z, Xu G, et al
    Long non-coding RNA XIST promotes TGF-beta-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Cancer Lett. 2018 Jan 12. pii: S0304-3835(18)30058.
    PubMed     Abstract available


  107. WU D, Zhao B, Qi X, Peng F, et al
    Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
    Cancer Lett. 2018 Jan 10. pii: S0304-3835(18)30052.
    PubMed     Abstract available


  108. WANG L, Syn NL, Subhash VV, Any Y, et al
    Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling.
    Cancer Lett. 2018 Jan 3. pii: S0304-3835(18)30003.
    PubMed     Abstract available


  109. FU XT, Shi YH, Zhou J, Peng YF, et al
    MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.
    Cancer Lett. 2018;412:108-117.
    PubMed     Abstract available


    December 2017
  110. LEE JY, Talhi O, Jang D, Cerella C, et al
    Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer.
    Cancer Lett. 2017;416:94-108.
    PubMed     Abstract available


  111. MAO Q, Jiang F, Yin R, Wang J, et al
    Interplay between the lung microbiome and lung cancer.
    Cancer Lett. 2017;415:40-48.
    PubMed     Abstract available


  112. TESSEMA M, Yingling CM, Picchi MA, Wu G, et al
    ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
    Cancer Lett. 2017;410:191-200.
    PubMed     Abstract available


  113. YOSHIKAWA Y, Takano O, Kato I, Takahashi Y, et al
    Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1alpha pathway.
    Cancer Lett. 2017;410:82-91.
    PubMed     Abstract available


    November 2017
  114. WANG J, Tian L, Khan MN, Zhang L, et al
    Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-kappaB mediated epithelial-mesenchymal transition and stemness.
    Cancer Lett. 2017 Nov 30. pii: S0304-3835(17)30762.
    PubMed     Abstract available


  115. XUE X, Fei X, Hou W, Zhang Y, et al
    miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer.
    Cancer Lett. 2017;412:170-178.
    PubMed     Abstract available


  116. JING L, Song F, Liu Z, Li J, et al
    MLKL-PITPalpha signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells.
    Cancer Lett. 2017 Nov 2. pii: S0304-3835(17)30693.
    PubMed     Abstract available


    October 2017
  117. LIU X, Chen B, You W, Xue S, et al
    The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
    Cancer Lett. 2017 Oct 23. pii: S0304-3835(17)30652.
    PubMed     Abstract available


  118. LE HT, Nguyen HT, Min HY, Hyun SY, et al
    Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells.
    Cancer Lett. 2017 Oct 20. pii: S0304-3835(17)30648.
    PubMed     Abstract available


  119. LI X, Ma T, Zhang Q, Chen YG, et al
    Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population.
    Cancer Lett. 2017;406:22-26.
    PubMed     Abstract available


  120. TANG ZH, Cao WX, Guo X, Dai XY, et al
    Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.
    Cancer Lett. 2017 Oct 9. pii: S0304-3835(17)30624.
    PubMed     Abstract available


  121. TORRES-DURAN M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, et al
    Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.
    Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30603.
    PubMed     Abstract available


  122. YANG H, Lee MH, Park I, Jeon H, et al
    HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
    Cancer Lett. 2017;411:19-26.
    PubMed     Abstract available


  123. BETTI M, Casalone E, Ferrante D, Aspesi A, et al
    Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
    Cancer Lett. 2017;405:38-45.
    PubMed     Abstract available


    September 2017
  124. HUANG GX, Wang Y, Su J, Zhou P, et al
    Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30552.
    PubMed     Abstract available


  125. KIM SJ, Jung KH, Son MK, Park JH, et al
    Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.
    Cancer Lett. 2017;403:339-353.
    PubMed     Abstract available


  126. CHAN KK, Leung CO, Wong CC, Ho DW, et al
    Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.
    Cancer Lett. 2017;403:330-338.
    PubMed     Abstract available


  127. CAO L, Qi L, Zhang L, Song W, et al
    Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ss signaling pathway in lung adenocarcinoma.
    Cancer Lett. 2017;403:246-259.
    PubMed     Abstract available


  128. LIU CH, Lan CT, Chou JF, Tseng TJ, et al
    CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.
    Cancer Lett. 2017;403:280-288.
    PubMed     Abstract available


  129. LIANG Z, Cheng Y, Chen Y, Hu Y, et al
    EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs.
    Cancer Lett. 2017;403:186-194.
    PubMed     Abstract available


  130. WANG C, Zhou X, Li W, Li M, et al
    Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Cancer Lett. 2017;403:271-279.
    PubMed     Abstract available


  131. ZHOU J, Zhang S, Chen X, Zheng X, et al
    Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancer.
    Cancer Lett. 2017 Sep 1. pii: S0304-3835(17)30518.
    PubMed     Abstract available


    August 2017
  132. BAI Z, Gao M, Zhang H, Guan Q, et al
    BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Cancer Lett. 2017;402:81-92.
    PubMed     Abstract available


  133. WANG ZQ, He CY, Hu L, Shi HP, et al
    Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.
    Cancer Lett. 2017 Aug 23. pii: S0304-3835(17)30490.
    PubMed     Abstract available


  134. ZHOU L, Lv T, Zhang Q, Zhu Q, et al
    The biology, function and clinical implications of exosomes in lung cancer.
    Cancer Lett. 2017 Aug 12. pii: S0304-3835(17)30480.
    PubMed     Abstract available


  135. PARK KS, Yang H, Choi J, Seo S, et al
    The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30464.
    PubMed     Abstract available


  136. PISANU ME, Noto A, De Vitis C, Morrone S, et al
    Blockade of Stearoyl-CoA-Desaturase 1 activity reverts resistance to Cisplatin in lung cancer stem cells.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30463.
    PubMed     Abstract available


  137. LI J, Tian H, Pan J, Jiang N, et al
    Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer.
    Cancer Lett. 2017 Aug 5. pii: S0304-3835(17)30466.
    PubMed     Abstract available


  138. YANG D, Cao X, Wang F, Jiang H, et al
    LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
    Cancer Lett. 2017;400:137-148.
    PubMed     Abstract available


  139. WU J, He Z, Yang XM, Li KL, et al
    RCCD1 depletion attenuates TGF-beta-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells.
    Cancer Lett. 2017;400:18-29.
    PubMed     Abstract available


    July 2017
  140. TONG CWS, Wu WKK, Loong HHF, Cho WCS, et al
    Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer.
    Cancer Lett. 2017 Jul 31. pii: S0304-3835(17)30459.
    PubMed     Abstract available


  141. STAPELFELD C, Neumann KT, Maser E
    Different inhibitory potential of sex hormones on NNK detoxification in vitro: a possible explanation for gender-specific lung cancer risk.
    Cancer Lett. 2017 Jul 22. pii: S0304-3835(17)30451.
    PubMed     Abstract available


  142. MENG X, Liu Y, Zhang J, Teng F, et al
    PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges.
    Cancer Lett. 2017 Jul 6. pii: S0304-3835(17)30415.
    PubMed     Abstract available


  143. GORZALCZANY Y, Akiva E, Klein O, Merimsky O, et al
    Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor.
    Cancer Lett. 2017;397:23-32.
    PubMed     Abstract available


    June 2017
  144. BROCK M, Mei Y
    Protein functional effector sncRNAs (pfeRNAs) in lung cancer.
    Cancer Lett. 2017 Jun 19. pii: S0304-3835(17)30394.
    PubMed     Abstract available


  145. DENG M, Zeng C, Lu X, He X, et al
    miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Cancer Lett. 2017 Jun 17. pii: S0304-3835(17)30387.
    PubMed     Abstract available


  146. CHANG TH, Tsai MF, Gow CH, Wu SG, et al
    Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Cancer Lett. 2017;402:190-202.
    PubMed     Abstract available


  147. CHANG YC, Chan YC, Chang WM, Lin YF, et al
    Feedback regulation of ALDOA activates the HIF-1alpha/MMP9 axis to promote lung cancer progression.
    Cancer Lett. 2017;403:28-36.
    PubMed     Abstract available


  148. KWON OS, Hong SK, Kwon SJ, Go YH, et al
    BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.
    Cancer Lett. 2017 Jun 10. pii: S0304-3835(17)30355.
    PubMed     Abstract available


  149. DONG X, Liao W, Zhang L, Tu X, et al
    RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Cancer Lett. 2017 Jun 6. pii: S0304-3835(17)30370.
    PubMed     Abstract available


  150. NERI S, Miyashita T, Hashimoto H, Suda Y, et al
    Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.
    Cancer Lett. 2017;395:20-30.
    PubMed     Abstract available


    May 2017
  151. SILVA PM, Ribeiro N, Lima RT, Andrade C, et al
    Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel.
    Cancer Lett. 2017;394:33-42.
    PubMed     Abstract available


  152. CHEN S, Dong Z, Yang P, Wang X, et al
    Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
    Cancer Lett. 2017;394:22-32.
    PubMed     Abstract available


  153. CASTANON E, Soltermann A, Lopez I, Roman M, et al
    The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
    Cancer Lett. 2017 May 24. pii: S0304-3835(17)30342.
    PubMed     Abstract available


  154. ZHANG J, Kong L, Jiao Q, Li M, et al
    Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead.
    Cancer Lett. 2017 May 16. pii: S0304-3835(17)30311.
    PubMed     Abstract available


    April 2017
  155. WANG Y, Zhou Y, Tao F, Chai S, et al
    N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
    Cancer Lett. 2017 Apr 26. pii: S0304-3835(17)30292.
    PubMed     Abstract available


    February 2017
  156. SHEN CJ, Chan SH, Lee CT, Huang WC, et al
    Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
    Cancer Lett. 2017;386:110-122.
    PubMed     Abstract available


    November 2016
  157. KIM JY, Lee N, Kim YJ, Cho Y, et al
    Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
    Cancer Lett. 2016 Nov 25. pii: S0304-3835(16)30710.
    PubMed     Abstract available


  158. ZYSK A, DeNichilo MO, Panagopoulos V, Zinonos I, et al
    Adoptive transfer of ex vivo expanded Vgamma9Vdelta2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.
    Cancer Lett. 2016 Nov 16. pii: S0304-3835(16)30699.
    PubMed     Abstract available


    July 2016
  159. KONG J, Sun W, Li C, Wan L, et al
    Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
    Cancer Lett. 2016;380:476-484.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: